Rasuvo Injection, Solution
Product Images NDC 59137-520

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rasuvo (NDC 59137-520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medexus Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rasuvo 01)

Chemical structure diagram of methotrexate, the active ingredient in Rasuvo. The structure shows the molecular arrangement with labeled bonds and atoms including nitrogen, oxygen, and carbon groups.*

FDA Label Image

Figure A (Rasuvo 02)

Rasuvo 7.5 mg (methotrexate) injection packaging label for a subcutaneous injection solution. The label indicates 7.5 mg per 0.15 mL strength with four pre-assembled 0.15 mL pre-filled Rasuvo auto-injectors in the carton. The labeler is Medexus Pharma Inc., and the product is for prescription use only. The label includes dosing instructions and storage conditions.*

FDA Label Image

Figure B (Rasuvo 03)

Rasuvo 10 mg injection carton label for subcutaneous use, containing methotrexate solution 10 mg per 0.20 mL pre-filled auto-injectors. The packaging displays the brand name and generic name, dosing strength, and manufacturer Medexus Pharma Inc. It includes storage instructions and an image of the auto-injector device.*

FDA Label Image

Figure C (Rasuvo 04)

Packaging label for Rasuvo 12.5 mg methotrexate injection solution, 0.25 mL per dose, for subcutaneous use. The label features the brand name Rasuvo prominently alongside the generic name methotrexate, and includes storage instructions, usage cautions, and a visual representation of a pre-filled auto-injector. The label identifies Medexus Pharma Inc. as the manufacturer and includes a barcode and NDC number 59137-515-04.*

FDA Label Image

Figure D (Rasuvo 05)

Packaging label for Rasuvo 15 mg injection (methotrexate), a subcutaneous injection solution. The label shows the product name, strength (15 mg per 0.30 mL), and indicates that each carton contains four pre-assembled 0.30 mL pre-filled auto-injectors. Medexus Pharma Inc. is listed as the manufacturer. The label includes storage instructions and a barcode, alongside a visual of the auto-injector device.*

FDA Label Image

Figure E (Rasuvo 06)

Packaging label for Rasuvo 17.5 mg methotrexate injection, a subcutaneous solution. The label indicates a 0.35 mL pre-filled autoinjector containing 17.5 mg methotrexate. The labeler is Medexus Pharma Inc. The package includes drug identification, usage instructions, and storage conditions. The design features a pink and white color scheme with the Rasuvo logo and an image of the autoinjector.*

FDA Label Image

Figure F (Rasuvo 07)

Rasuvo 20 mg/mL (20 mg per 0.40 mL) methotrexate injection, solution for subcutaneous use. The label features the Rasuvo brand logo and includes manufacturer information for Medexus Pharma Inc. The packaging highlights the product as a 4 pre-assembled 0.40 mL pre-filled auto-injector carton and provides storage and handling instructions.*

FDA Label Image

Figure G (Rasuvo 08)

Packaging label for Rasuvo 22.5 mg (methotrexate) injection, 0.45 mL pre-filled solution for subcutaneous injection. The label shows the proprietary and generic names, strength, dosage form, and manufacturer, Medexus Pharma Inc. It includes usage instructions, storage conditions, an image of the pre-filled auto-injector syringe, and barcodes.*

FDA Label Image

Figure H (Rasuvo 09)

Rasuvo 25 mg (methotrexate) injection subcutaneous solution packaging label from Medexus Pharma Inc. The carton states 25 mg per 0.50 mL pre-filled auto-injectors, includes handling and storage information, and emphasizes subcutaneous use only. The label features the Rasuvo logo, dosage strength, and barcodes, with a visual of the auto-injector device.*

FDA Label Image

Principal Display Panel (7.5 mg Auto-Injector Carton)

Packaging label for Rasuvo 30 mg (methotrexate) injection, solution for subcutaneous injection. The label includes product strength (30 mg per 0.60 mL), the Rasuvo logo, and an image of a pre-filled auto-injector syringe. Labeler information shows Medexus Pharma Inc. The label also includes usage instructions noting it is for single use only and stored under specific temperature conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.